Alliance Global Partners Comments on Organigram Q1 Earnings

Organigram Holdings Inc. (TSE:OGI) – Equities research analysts at Alliance Global Partners lowered their Q1 2025 EPS estimates for shares of Organigram in a report issued on Wednesday, December 18th. Alliance Global Partners analyst A. Grey now expects that the company will post earnings per share of ($0.05) for the quarter, down from their prior forecast of ($0.02). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Alliance Global Partners also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.04) EPS, Q4 2025 earnings at ($0.04) EPS, FY2025 earnings at ($0.16) EPS and FY2026 earnings at ($0.11) EPS.

Several other analysts also recently issued reports on the company. ATB Capital reduced their price objective on Organigram from C$5.25 to C$3.50 in a research report on Tuesday, December 17th. Canaccord Genuity Group reduced their target price on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday, December 9th.

Organigram Price Performance

Shares of TSE:OGI opened at C$2.25 on Monday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. The business’s fifty day moving average price is C$2.25 and its two-hundred day moving average price is C$2.30. The stock has a market cap of C$244.28 million, a PE ratio of -0.90, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. Organigram has a one year low of C$1.67 and a one year high of C$3.95.

Insiders Place Their Bets

In related news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28. Corporate insiders own 31.32% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.